🇰🇷 Olumiant in South Korea

Olumiant (baricitinib) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

Olumiant in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in South Korea

Frequently asked questions

Is Olumiant approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Olumiant in South Korea?

Eli Lilly is the originator. The local marketing authorisation holder may differ — check the official source linked above.